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1. INTRODUCTION 
 
Psychological and physiological effects of marijuana are caused by binding of its 
active component (∆9-tetrahydrocannabinol) to cannabinoid receptors. The cannabinoid 
receptors belong to a family of G protein-coupled seven-transmembrane-domain 
receptors, and consist of type 1 (CB1) and type 2 (CB2) receptors with different 
distributions (Matsuda et al., 1990; Munro et al., 1993; Felder and Glass, 1998). The CB1 
receptor is expressed in the CNS, whereas the CB2 receptor is found in the immune 
system of the periphery (Klein et al., 1998). Activation of the CB1 receptor induces 
various effects on neural functions (Di Marzo et al., 1998; Felder and Glass, 1998), 
including suppression of neurotransmitter release (Gifford and Ashby, 1996; Ishac et al., 
1996; Shen et al., 1996; Katona et al., 1999; Hoffman and Lupica, 2000). Several 
molecules are identified as candidate endogenous ligands for cannabinoid receptors 
(endocannabinoids). Arachidonylethanolamide (anandamide) and 2-arachidonoylglycerol 
(2-AG), two major endocannabinoids, are reported to be synthesized from membrane 
phospholipids in an activity- and a Ca2+-dependent manners (Cadas et al., 1996; Stella et 
al., 1997; Di Marzo et al., 1998; Bisogno et al., 1999; Piomelli et al., 2000). It is thought 
that they can diffuse out across the cell membrane. The released endocanabinoids are 
removed from the extracellular space through uptake and enzymatic degradation 
(Mechoulam et al., 1998). All these findings suggest that endocannabinoids can work as a 
diffusible and short-lived mediator that is released from activated neurons, binds to 
cannabinoid receptors on neighboring neurons and modulate their functions. 
Recent electrophysiological studies have revealed that endocannabinoids play an 
important role in retrograde modulation of synaptic transmission in the CNS (Kreitzer 
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and Regehr, 2001b; Maejima et al., 2001a; Ohno-Shosaku et al., 2001; Wilson and Nicoll, 
2001). Endocannabinoids are released from postsynaptic neurons in response to either 
depolarization or activation of Gq/11-coupled receptors such as group I metabotropic 
glutamate receptors (mGluRs) and M1/M3 muscarinic acetylcholine receptors. The 
released endocannabinoids then activate presynaptic cannabinoid receptors and suppress 
transmitter release (Maejima et al., 2001b; Alger, 2002; Kano et al., 2002; Kreitzer and 
Regehr, 2002; Wilson and Nicoll, 2002; Freund et al., 2003; Kano et al., 2003; Piomelli, 
2003). Thus, the endocannabinoid signaling is an important mechanism by which 
postsynaptic neuronal activity can retrogradely influence presynaptic functions. In this 
review, we introduce recent electrophysiological studies on endocannabinoid-mediated 
retrograde modulation and discuss its possible physiological roles in the CNS. 
 
 
2. ENDOCANNABINOID-MEDIATED RETROGRADE MODULATION OF 
SYNAPTIC TRANSMISSION 
 
2.1. Depolarization-Induced Suppression of Inhibition (DSI) 
 
More than ten years ago, it was found that depolarization of a postsynaptic neuron 
induces transient suppression of inhibitory postsynaptic currents (IPSCs) recorded from 
the depolarized neuron in the cerebellum (Llano et al., 1991) and the hippocampus (Pitler 
and Alger, 1992; Ohno-Shosaku et al., 1998). This phenomenon was termed 
depolarization-induced suppression of inhibition (DSI). DSI is induced by a depolarizing 
voltage pulse with a long duration (several seconds). However, a train of action potentials 
can also induce DSI (Pitler and Alger, 1992; Morishita and Alger, 2001; Ohno-Shosaku 
et al., 2001), suggesting that DSI may occur physiologically in vivo. DSI lasts for tens of 
seconds and the magunitude of DSI depends on the duration of depolarization (Ohno-
Shosaku et al., 1998; Lenz and Alger, 1999). Injection of a fast Ca2+ cheleter, BAPTA, 
into the postsynaptic neuron inhibits DSI (Pitler and Alger, 1992; Vincent and Marty, 
1993; Ohno-Shosaku et al., 2001), indicating that elevation of postsynaptic Ca2+ 
concentration is required for the induction of DSI. DSI accompanies a clear increase in 
the paired-pulse ratio (Ohno-Shosaku et al., 1998; Wilson and Nicoll, 2001), a widely 
used indicator of presynaptic modulation (Zucker and Regehr, 2002), but not a 
comparable decrease in the postsynaptic sensitivity to the inhibitory transmitter GABA 
(Pitler and Alger, 1992; Ohno-Shosaku et al., 2001). These data indicate that the 
depolarization-induced elevation of intracellular Ca2+ concentration in the postsynaptic 
neuron induces suppression of GABA release from presynaptic terminals. Thus, it is 
evident that DSI requires a retrograde signal from depolarized postsynaptic neurons to 
presynaptic terminals. 
Recent electrophysiological studies have revealed that endocannabinoids mediate 
the retrograde signal of DSI, by using hippocampal cultures (Ohno-Shosaku et al., 2001), 
hippocampal slices (Wilson and Nicoll, 2001) and cerebellar slices (Kreitzer and Regehr, 
2001a; Diana et al., 2002; Yoshida et al., 2002). Our study on hippocampal cultures 
clearly demonstrates that hippocampal inhibitory synapses are heterogeneous in 
cannabinoid sensitivity (Ohno-Shosaku et al., 2001). The cannabinoid agonist 
WIN55,212-2 is effective only at a subset of inhibitory synapses, and suppresses GABA 
release through activation of the CB1 receptor (Ohno-Shosaku et al., 2001). DSI can be 
induced only at cannabinoid-sensitive synapses, and blocked by CB1 antagonists (AM 
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281 and SR141716A) (Fig. 1). These results clearly indicate that DSI is mediated by 
endocannabinoids (Ohno-Shosaku et al., 2001). Another study on hippocampal slices 
(Wilson and Nicoll, 2001) shows essentially the same results as those in cultures. Besides, 
DSI is not affected by postsynaptically-applied botulinum toxin (Wilson and Nicoll, 
2001), suggesting that vesicular release is not involved in DSI. In cerebellar slices, it is 
demonstrated that DSI of Purkinje cells is completely occluded by WIN55,212-2-induced 
suppression of inhibitory transmission, blocked by CB1 antagonists and deficient in CB1-
knockout mice (Kreitzer and Regehr, 2001a; Diana et al., 2002; Yoshida et al., 2002). 
Involvement of endocannabinoids in DSI has also been reported in other regions of the 
CNS including the basal ganglia (Wallmichrath and Szabo, 2002) and the neocortex 
(Trettel and Levine, 2003; Trettel et al., 2004). These findings strongly suggest that 





Figure 1. Retrograde modulation induced by depolarization at hippocampal inhibitory synapses. In the 
experiments shown in Figs. 1-4, inhibitory postsynaptic currents (IPSCs) were recorded from cultured 
hippocampal neurons prepared from rats, as described previously (Ohno-Shosaku et al., 2001). A. An example 
of DSI. When a postsynaptic neuron was depolarized from –80 mV to 0 mV for 5 sec, the amplitude of IPSCs 
was transiently decreased. B: After the treatment with the cannabinoid antagonist AM281 (0.3 µM), the 
depolarization failed to induce DSI. IPSC traces acquired at the indicated time points are shown on the right. 
 
 
2.2. Depolarization-Induced Suppression of Excitation (DSE) 
 
Endocannabinoids released from depolarized postsynaptic neurons can also 
suppress transmitter release from excitatory presynaptic terminals. Depolarization of 
cerebellar Purkinje cells induces transient suppression of excitatory postsynaptic currents 
(EPSCs) elicited by stimulation of climbing fibers or parallel fibers (Kreitzer and Regehr, 
T. OHNO-SHOSAKU ET AL. 4 
2001b; Maejima et al., 2001a). This depolarization-induced suppression of excitation 
(DSE) lasts for tens of seconds, is blocked by postsynaptic injection of BAPTA, and 
accompanies a clear change in the paired-pulse ratio (Kreitzer and Regehr, 2001b). DSE 
is blocked by CB1 antagonists (Kreitzer and Regehr, 2001b), and deficient in CB1-
knockout mice (our unpublished data). All these properties are quite similar to those of 
DSI. These results indicate that endocannabinoids are released from depolarized Purkinje 
cells, and suppress the release of the excitatory transmitter glutamate through activation 
of the presynaptic CB1 receptor. 
DSE can also be induced in other brain regions including the hippocampus (Ohno-
Shosaku et al., 2002b) and ventral tegmental area (Melis et al., 2004). In the 
hippocampus, however, DES is less prominent than DSI. The duration of depolarization 
required for DSE induction is longer than that for DSI, and the magnitude of DSE is 
much smaller than that of DSI when the neuron is fully depolarized. It is demonstrated 
that EPSCs are less sensitive to WIN55,212-2 than the cannabinoid-sensitive IPSCs. 
Thus, presynaptic cannabinoid sensitivity appears to be a major factor that determines the 
extent of endocannabinoid-mediated suppression. 
While the cerebellar DSE is clearly CB1-dependent, identity of the cannabinoid 
receptor involved in the hippocampal DSE is controversial. It is reported that the third yet 
unidentified subtype of cannabinoid receptor (CB3) exists at excitatory synapses in adult 
hippocampal slices (Hajos et al., 2001; Kofalvi et al., 2003). This is based on the 
experimental results that the suppression of excitatory synaptic transmission (Hajos et al., 
2001) or glutamate release (Kofalvi et al., 2003) by WIN55,212-2 is present in CB1-
knockout mice, but the effect is sensitive to the cannabinoid antagonist SR141716A. 
However, our results on cultured hippocampal neurons indicate that both DSE and the 
suppression of EPSCs by WIN55,212-2 are totally deficient in CB1-knockout mice 
(Ohno-Shosaku et al., 2002b). The reason for this discrepancy is unclear. It is possible 
that the putative CB3 receptor is not expressed in immature neurons, but appears later in 
adult animals. The molecular identity and the expression pattern of the putative CB3 
receptor, if exists, remain to be elucidated. 
 
2.3. Retrograde Modulation Induced by mGluR Activation 
 
In addition to depolarization, postsynatpic activation of certain types of receptors 
can induce endocannabinoid-mediated retrograde suppression. This type of modulation 
was originally found in cerebellar Purkinje cells (Maejima et al., 2001a). In mouse 
cerebellar slices, application of a group I mGluR agonist, (RS)-3,5-
dihydroxyphenylglycine (DHPG), induces suppression of climbing fiber-mediated EPSCs 
(CF-EPSCs) recorded from Purkinje cells. Several lines of evidence indicate that this 
suppression is caused by activation of mGluR subtype 1 (mGluR1), a member of group I 
mGluRs, at postsynaptic Purkinje cells. Firstly, the DHPG-induced suppression is 
blocked by postsynaptic injection of GDP-β-S or GTP-γ-S. Secondly, the suppression is 
absent in the mGluR1-knockout mouse. Finally, this defect is restored in the mGluR1-
rescue mouse in which rat mGluR1α is introduced into the mGluR1-knockout mouse by 
using a Purkinje cell specific promotor. Although the induction is postsynaptic, the 
expression of this suppression is clearly presynaptic. The DHPG-induced suppression is 
associated with a clear increase in the paired-pulse ratio, indicating that the suppression is 
caused by the reduction of glutamate release from presynaptic terminals. Therefore, some 
retrograde signal must exist for this synaptic modulation. It is demonstrated that this 
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retrograde signal is also mediated by endocannabinoids. The DHPG-induced suppression 
of CF-EPSCs is mimicked and occluded by the cannabinoid agonist WIN55,212-2, and 
blocked by CB1 antagonists. Thus, activation of mGluR1 on postsynaptic Purkinje cells 
stimulates production and release of endocannabinoids, which retrogradely act on the 
presynaptic CB1 receptor and suppress glutamate release from climbing fiber terminals. 
Importantly, this mGluR-induced endocannabinoid release does not require elevation of 
intracellular Ca2+ concentration in postsynaptic Purkinje cells, forming a striking contrast 
to the depolarization-induced release of endocannabinoids. Thus, the endocannabinoid-
mediated retrograde modulation can be initiated by two distinct stimuli, namely the 
depolarization-induced Ca2+ elevation and the mGluR1 activation. Furthermore, it should 
be noted that the activation of mGluR1 by synaptically released glutamate after repetitive 
stimulation of parallel fibers, the other excitatory inputs to Purkinje cells, causes transient 
cannabinoid-dependent suppression of CF-EPSCs (Maejima et al., 2001a). This result 
suggests that the mGluR1-mediated generation of the endocannabinoid signal is 





Figure 2. Retrograde modulation induced by activation of group I mGluRs at hippocampal inhibitory synapses. 
A. Application of a group I mGluR agonist, DHPG (50 µM), induced a suppression of IPSCs. B. This DHPG-
induced suppression was blocked by the AM281 treatment. 
 
 
The endocannabinoid-mediated retrograde modulation triggered by activation of 
group I mGluRs was also found at hippocampal inhibitory synapses (Varma et al., 2001; 
Ohno-Shosaku et al., 2002a). A study on cultured hippocampal neurons demonstrates that 
DHPG suppresses cannabinoid-sensitive IPSCs (Fig. 2A), but not cannabinoid-insensitive 
IPSCs (Ohno-Shosaku et al., 2002a). This effect is largely blocked by an antagonist 
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specific to mGluR subtype 5 (mGluR5), the other member of group I mGluRs. The 
DHPG-induced suppression is associated with an increase in the paired-pulse ratio, and 
blocked by CB1 antagonists (Fig. 2B) (Ohno-Shosaku et al., 2002a), indicating that the 
activation of group I mGluRs (mostly mGluR5) produces endocannabinoids and 
suppresses GABA release from cannabinoid-sensitive presynaptic terminals through 
activation of the CB1 receptor. 
 
2.4. Retrograde Modulation Induced by Muscarinic Activation 
 
Activation of muscarinic receptors produces various effects on neuronal functions 
in the CNS. Application of cholinergic or muscarinic agonists depresses synaptic 
transmission in various regions of the brain, primarily by suppressing transmitter release. 
Recently, it was demonstrated that muscarinic suppression of hippocampal inhibitory 
transmission is partly cannabinoid-dependent in slices (Kim et al., 2002) and cultured 
neurons (Fukudome et al., 2004). In the latter study, it is shown that two distinct 
mechanisms mediate the muscarinic suppression. At a subset of synapses, activation of 
the presynaptic M2 receptor suppresses GABA release directly. In contrast, at a different 
subset of synapses, activation of the postsynatpic M1/M3 receptors causes 
endocannabinoid release and subsequently suppresses GABA release by activating the 





Figure 3. Retrograde modulation induced by activation of muscarinic receptors at hippocampal inhibitory 
synapses. A. Application of a muscarinic agonist, oxotremoline-M (3 µM), induced suppression of IPSCs under 
the blockade of the presynaptic M2 muscarinic receptor by gallamine (100 µM). B. This suppression was 
blocked by the AM281 treatment. 
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Since both group I mGluRs and M1/M3 receptors are coupled to Gq/11 proteins and 
capable to trigger endocannabinoid production, it is possible that other Gq/11-coupled 
receptors can also be involved in the retrograde modulation by triggering 
endocannabinoid signaling in the CNS. In this context, it is interesting that the activation 
of G-protein-coupled corticosteroid receptor triggers the endocannabinoid release and 
suppresses the glutamate release retrogradely in the hypothalamus (Di et al., 2003), 
although the molecular identity of this receptor is not clear. 
 
2.5. Interaction between the Depolarization and the Activation of Gq/11-coupled 
Receptors 
 
As described above, endocannabinoid release can be triggered by the two distinct 
stimuli, namely the depolarization-induced Ca2+ elevation and the activation of Gq/11-
coupled receptors. These two pathways may interact each other, because simultaneous 
application of these two stimuli produces a synergistic effect (Varma et al., 2001; Kim et 
al., 2002; Ohno-Shosaku et al., 2002a; Ohno-Shosaku et al., 2003). 
 The activation of group I mGluRs by DHPG enhances DSI in hippocampal slices 
(Varma et al., 2001; Ohno-Shosaku et al., 2002a) and cultures (Fig. 4A) (Ohno-Shosaku 
et al., 2002a). This enhancement is much more prominant (about 7-times higer) than what 
is expected from the simple summation of the depolarization-induced and the group I 
mGluR-induced endocannabinoid release (Ohno-Shosaku et al., 2002a). DHPG causes no 
change in depolarization-induced Ca2+ transients, indicating that the enhanced DSI by 
DHPG is not due to the augmentation of Ca2+ influx. These results suggest that the two 
pathways work in a cooperative manner to release endocannabinoids, at least partly, 





Figure 4. Synergistic effect of depolarization and receptor activation on retrograde suppression. A. DSI induced 
by a brief depolarization (1 sec) was enhanced by 5 µM DHPG. B. DSI induced by a brief depolarization (1 sec) 
was enhanced by 0.3 µM oxotremoline-M.  
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Activation of muscarinic receptors also enhances DSI in hippocampal slices (Kim et 
al., 2002) and cultures (Ohno-Shosaku et al., 2003). The cholinergic agonist carbachol 
(CCh) markedly enhances DSI at 0.01-0.3 µM without changing the presynaptic 
cannabinoid sensitivity (Ohno-Shosaku et al., 2003). The facilitating effect of CCh on 
DSI is mimicked by a muscarinic agonist (Fig. 4B), and blocked by a muscarinic 
antagonist. It is also blocked by intracellular injection of GDP-β-S to postsynaptic 
neurons. By using knockout mice lacking one or two subtypes of muscarinic receptors, it 
is shown that both M1 and M3 receptors are involved in the muscarinic enhancement of 
DSI (Ohno-Shosaku et al., 2003). These results indicate that the activation of the 
postsynaptic M1/M3 receptors facilitates the depolarization-induced release of 
endocannabinoids in the hippocampus. 
In addition to these Gq/11-coupled receptors, D2 dopamine receptors might be also 
involved in the modulation of endocannabinoid signalling. In ventral tegmental area 
dopamine neurons, DSE is partially blocked by a D2 antagonist, and enhanced by a D2 
agonist without changing the presynaptic cannabinoid sensitivity (Melis et al., 2004). 
Although the D2 receptor is Gi/o-coupled, the authors suggest that its enhancing effect on 
DSE might be caused by the stimulation of PLC, probably through βγ subunits.   
 
2.6. Limited Diffusion of Endocannabinoids 
 
The released endocannabinoids to the extracellular space are thought to be removed 
rapidly by uptake and enzymatic degradation (Di Marzo et al., 1998; Piomelli et al., 
2000). The limited diffusion of endocannabinoids is reported in several 
electrophysiologial studies on hippocampal and cerebellar slices. In hippocampal slices, it 
is shown that endocannabinoids released by depolarization can affect only the synapses 
on neighboring neurons located within 20 µm from the depolarized neurons (Wilson and 
Nicoll, 2001). In cerebellar slices, it is demonstrated that endocannabinoids released from 
a Purkinje cell can not spread to the synaptic terminals onto neighboring Purkinje cells 
(Maejima et al., 2001a) but can spread to closely located interneurons (Kreitzer et al., 
2002). These results indicate that the diffusion of endocannabinoids is rather limited in 
brain tissues. Thus, endocannabinoids can function as a spatially limited local signal in 
the CNS. 
 
2.7. Current Model of Endocannabinoid-Mediated Retrograde Modulations 
 
Figure 5 shows a current model for the mechanisms of endocannabinoid-mediated 
retrograde modulations. Postsynaptic depolarization triggers Ca2+ influx by activating 
voltage-gated Ca2+ channels, and causes transient elevation of intracellular Ca2+ 
concentration. This Ca2+ elevation and the activation of Gq/11–coupled receptors such as 
group I mGluRs and M1/M3 muscarinic receptors work in a cooperative manner to 
produce and release endocannabinoids. The released endocannabinoids diffuse 
retrogradely and bind to the CB1 receptor on excitatory or inhibitory presynaptic 
terminals. The binding of endocannabinoids to the CB1 receptor activates Gi/o proteins 
and suppresses the release of glutamate or GABA, presumably by inhibiting voltage-
gated Ca2+ channels (Hoffman and Lupica, 2000; Guo and Ikeda, 2004), activating K+ 
channels (Daniel and Crepel, 2001; Guo and Ikeda, 2004) or inhibiting vesicular release 
machinery directly (Takahashi and Linden, 2000). 
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Figure 5. A current model of endocannabinoid-mediated retrograde modulations at central synapses. 
 
 
2.8. Wide Distribution of the Presynaptic CB1 and Postsynaptic Gq/G11-coupled 
Receptors in the CNS 
 
Elevation of intracellular Ca2+ concentration that triggers endocannabinoid release 
can be induced by a variety of neural activity through voltage-gated Ca2+ channels, 
NMDA receptors and Ca2+ release channels on intracellular stores. Most neurons in the 
CNS express group I mGluRs on their postsynaptic sites (Abe et al., 1992; Shigemoto et 
al., 1992; Shigemoto et al., 1997; Thomas et al., 1997). M1/M3 muscarinic receptors are 
also widely distributed in the CNS. In addition, the CB1 receptor is expressed at 
presynaptic terminals in various regions of the brain (Herkenham et al., 1990; Matsuda et 
al., 1993; Egertova and Elphick, 2000). Therefore, the endocannabinoid-mediated 
retrograde modulation observed in the hippocampus and the cerebellum may be a general 
mechanism, through which postsynaptic Ca2+ elevation and/or activation of Gq/G11-
coupled receptors can influence presynaptic functions. 
 
 
3. FUNCTIONAL SIGNIFICANCE OF THE ENDOCANNABINOID-MEDIATED 
RETROGRADE MODULATION 
 
What could be a functional role of the endocannabinoid-mediated retrograde 
modulation in the CNS? If endocannabinoids released from an activated neuron suppress 
its excitatory and inhibitory inputs to the same extent, the excitatory-inhibitory balance of 
the activated neuron will remain unchanged. In the hippocampus, however, there is a 
substantial difference in cannabinoid sensitivity between excitatory and inhibitory inputs. 
When a small amount of endocannabinoid is released from the activated postsynatpic 
neuron, the cannabinoid-sensitive inhibitory input will be selectively suppressed because 
of its high cannabinoid sensitivity. Under this condition, the endocannabinoid signal will 
exert net excitatory action on the postsynaptic neuron. When a large amount of 
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endocannabinoid is released, both the excitatory and the cannabinoid-sensitive inhibitory 
inputs will be suppressed, but the cannabinoid-insensitive inhibitory input is intact. Under 
this condition, the endocannabinoid signal will exert net inhibitory action. Thus, 
endocannabinoids can control the excitatory-inhibitory balance depending on the 
postsynaptic activity in the hippocampus.  
In addition to the short-term modulation, several recent studies suggest that the 
endocannabinoid system might also be involved in long-term synaptic plasticity, learning 
and memory. The induction of long-term potentiation (LTP) of the excitatory 
transmission in the hippocampus is facilitated during DSI (Carlson et al., 2002). Long-
term depression (LTD) of the excitatory transmission in the striatum (Gerdeman et al., 
2002; Robbe et al., 2002; Ronesi et al., 2004) and the neocortex (Sjöström et al., 2003) is 
suppressed by cannabinoid antagonists, and the striatal LTP is absent in CB1-knockout 
mice. LTD of the inhibitory transmission in the basolateral amygdala (Marsicano et al., 
2002) and the hippocampus (Chevaleyre and Castillo, 2003) is also suppressed by 
cannabinoid antagonists. Furthermore, the extinction of certain forms of memory 
(Marsicano et al., 2002; Varvel and Lichtman, 2002) is reported to be impaired in CB1-
knockout mice. Precise mechanisms for the roles of the endocannabinoid system in long-
term synaptic plasticity, learning and memory remain to be investigated. 
 
 
4. UNRESOLVED QUESTIONS 
 
Several important questions remain unanswered. (1) What molecule(s) (anandamide, 
2-AG or some other endocannabinoids) contributes to the retrograde modulation induced 
by the depolarization and/or the receptor activation? (2) What biochemical pathways are 
involved and which enzyme(s) is rate-limiting in the generation of endocannabinoids? (3) 
How do the depolarization and the receptor activation interact in the production and 
release of endocannabinoid? (4) How are endocannabinoids released across the cell 
membrane to the extracellular space and uptaken into the cells? (5) How does the 
activation of the presynaptic CB1 receptor lead to the suppression of transmitter release? 
(6) How are endocannabinoids involved in long-term synaptic plasticity, learning and 
memory? (7) How does the endocannabinoid signaling contribute to higher brain 
functions? Future studies should answer these important questions from the 
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